$HIPH -Announces Development of Prototype Aerosol Sanitizer

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
245
$HIPH -Announces Development of Prototype Aerosol Sanitizer Machine Using Proprietary Hydro-Nano Water

*Recent news/ pr just out a few days ago ,nice!

GlobeNewswireApril 22, 2020
The Device is Currently in the Developmental Stage Pending Significant Testing Prior to Certification for Commercial Use
PLAYA VISTA, CA, April 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – American Premium Water Corporation (HIPH) announces that it has developed a prototype device that aerosolizes a mixture of the Company’s proprietary Hydro-Nano water and disinfectant agents. This prototype device is currently in the developmental phase; extensive research, environmental, and laboratory testing will be required to be completed before the device and Hydro-Nano water mixture can be commercialized. The Company previously published results in April 2019 on the efficacy of its Hydro Nano technology. The report showed that the synthesis in the Company’s Hydro Nano water reduces the size of the majority of the CBD molecules encapsulated to one nanometer or less in diameter. A full copy of the report can be found here.
The Hydro-Nano water used in the prototype does not contain CBD or any hemp material. The prototype device, which aerosolizes a mixture of Hydro Nano water with disinfecting agents. The Company hypothesizes that the Hydro Nano water will have the same effect on the added sterilizing agents as it does with CBD, shrinking the size of the particles to less than one nanometer in size, which will lead to a more effective sterilizing solution by creating a cloud that will disinfect contact surfaces, and potentially the atmosphere in a room or building. To date, there has not been any testing done by the Company to support or make any claims of sterilization or disinfectant potency about this device or the contents contained in it. A video of the prototype device and its process can be found here.
American Premium CEO Ryan Fishoff commented, “I am pleased to announce the completion of a prototype device that aerosolizes our Hydro Nano water mixed with disinfectants. This is the first step in a long process to develop a usable and scalable product for commercial distribution. Current world events have placed a much greater emphasis on sanitation and sterilization, and the Company believes this device could potentially fulfill that need. The development of this prototype is the first of many steps towards a viable commercial device and formulation; significant laboratory and environmental testing has to be conducted before this device can be sold. But the potential is great; there are many commercial customers that could utilize this technology such as hotels, malls, movie theaters, department stores, boutiques, hospitals, and other retail businesses that would benefit from a quick and effective sanitation solution. I have always felt that the Company’s nanotechnology is a tremendous asset that gets overlooked; there are many potential applications of this technology beyond CBD and hemp. The Company will continue to explore ways to leverage our proprietary nanotech to create shareholder value. I look forward to updating shareholders on our progress in testing, achieving other milestones in the development process of this device, and other avenues that the Company is exploring to monetize existing nanotechnology,” concluded Mr. Fishoff
Vanexxe 2oz can be purchased on Amazon here.
Goldman Research initiated coverage of the Company on February 13th, 2020, giving a $0.0125 price target. To read the full report, click here
About American Premium Water Corp.
American Premium Water (HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) plant + body essentials (www.plantbodyessentials.com).
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading